6.
Sanders G, Neumann P, Basu A, Brock D, Feeny D, Krahn M
. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. JAMA. 2016; 316(10):1093-103.
DOI: 10.1001/jama.2016.12195.
View
7.
Standfield L, Comans T, Scuffham P
. An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting. Eur J Health Econ. 2015; 18(1):33-47.
DOI: 10.1007/s10198-015-0756-z.
View
8.
van de Ven M, IJzerman M, Retel V, van Harten W, Koffijberg H
. Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer. BMC Med Res Methodol. 2022; 22(1):83.
PMC: 8962015.
DOI: 10.1186/s12874-022-01571-3.
View
9.
Wright S, Newman W, Payne K
. Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review. Pharmacoeconomics. 2019; 37(8):1011-1027.
PMC: 6597608.
DOI: 10.1007/s40273-019-00801-9.
View
10.
Sharp L, Tilson L, Whyte S, Ceilleachair A, Walsh C, Usher C
. Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Serv Res. 2013; 13:105.
PMC: 3637462.
DOI: 10.1186/1472-6963-13-105.
View
11.
Fenwick E, Claxton K, Sculpher M
. The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008; 28(1):21-32.
DOI: 10.1177/0272989X07308751.
View
12.
Stahl J, Rattner D, Wiklund R, Lester J, Beinfeld M, Gazelle G
. Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making. 2004; 24(5):461-71.
DOI: 10.1177/0272989X04268951.
View
13.
Garrison Jr L, Mansley E, Abbott 3rd T, Bresnahan B, Hay J, Smeeding J
. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health. 2009; 13(1):8-13.
DOI: 10.1111/j.1524-4733.2009.00660.x.
View
14.
Bozzani F, Diaconu K, Gomez G, Karat A, Kielmann K, Grant A
. Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa. Health Policy Plan. 2021; 37(3):369-375.
PMC: 8896337.
DOI: 10.1093/heapol/czab155.
View
15.
Wright S, Newman W, Payne K
. Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine. Med Decis Making. 2021; 42(4):538-553.
PMC: 9005833.
DOI: 10.1177/0272989X211053792.
View
16.
Lacinova K, Thokala P, Nicholas R, Dobay P, Scalfaro E, Angehrn Z
. ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients. Appl Health Econ Health Policy. 2022; 20(5):731-742.
PMC: 9117085.
DOI: 10.1007/s40258-022-00733-0.
View
17.
Damschroder L, Reardon C, Widerquist M, Lowery J
. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022; 17(1):75.
PMC: 9617234.
DOI: 10.1186/s13012-022-01245-0.
View
18.
van Baal P, Morton A, Severens J
. Health care input constraints and cost effectiveness analysis decision rules. Soc Sci Med. 2018; 200:59-64.
PMC: 5906649.
DOI: 10.1016/j.socscimed.2018.01.026.
View
19.
Crane G, Kymes S, Hiller J, Casson R, Martin A, Karnon J
. Accounting for costs, QALYs, and capacity constraints: using discrete-event simulation to evaluate alternative service delivery and organizational scenarios for hospital-based glaucoma services. Med Decis Making. 2013; 33(8):986-97.
DOI: 10.1177/0272989X13478195.
View
20.
Thokala P, Dixon S, Jahn B
. Resource modelling: the missing piece of the HTA jigsaw?. Pharmacoeconomics. 2014; 33(3):193-203.
DOI: 10.1007/s40273-014-0228-9.
View